Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.

J. Catella-Chatron (St-Etienne, France), A. Merah (St-Etienne, France), E. De Magalhaes (St-Etienne, France), N. Moulin (St-Etienne, France), S. Accassat (St-Etienne, France), C. Duvillard (St-Etienne, France), P. Mismetti (St-Etienne, France), L. Bertoletti (St-Etienne, France)

Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Session: Pulmonary embolism: long-term sequelae and advances in therapies
Session type: Oral Presentation
Number: 3804
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Catella-Chatron (St-Etienne, France), A. Merah (St-Etienne, France), E. De Magalhaes (St-Etienne, France), N. Moulin (St-Etienne, France), S. Accassat (St-Etienne, France), C. Duvillard (St-Etienne, France), P. Mismetti (St-Etienne, France), L. Bertoletti (St-Etienne, France). Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.. 3804

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: